Tag: ulcerative colitis support
A Swallowable Pill Could Replace Colonoscopies for IBD Patients
Researchers are developing a swallowable ‘magnetic pill’ that could replace many colonoscopies with a simple, non-invasive procedure. For IBD patients who need frequent monitoring, this technology could be life-changing.
Finally, Clearer Answers: New Study Compares IBD Imaging Options
New research directly compares MRI and CT imaging for IBD, showing both are highly effective but excel in different areas. This evidence supports personalized imaging approaches that consider individual patient factors like age, symptoms, and long-term monitoring needs.
Asia-Pacific’s IBD Crisis: Why Early Action Could Change Everything
Asia-Pacific countries are developing new strategies to tackle rising IBD rates through early intervention and comprehensive care. This shift could transform outcomes for millions living with Crohn’s disease and ulcerative colitis in the region.
New Hope: STELARA Seeks FDA Approval for Kids with UC
Johnson & Johnson has submitted an FDA request for STELARA approval in pediatric ulcerative colitis patients. This could become the first biologic targeting dual inflammation pathways specifically for children with UC, offering new hope for families with limited treatment options.
After Surgery, IBD Can Still Surprise Us: A Facial Wound’s Message
A woman who thought her ulcerative colitis was cured by surgery developed a rare facial skin condition years later, revealing that IBD can continue affecting the body in unexpected ways. This case highlights why ongoing vigilance and comprehensive care remain important even after major IBD surgery.
New Once-Monthly UC Treatment Approved: What Patients Need to Know
The FDA has approved Omvoh, the first once-monthly injection for ulcerative colitis maintenance therapy. This breakthrough could significantly reduce treatment burden for people with moderate to severe UC.
New Clinical Leader Brings Hope to GI Treatment Development
Palisade Bio has appointed Dr. Sharon Skare as VP of Clinical Operations to advance PALI-2108, a promising new GI therapy. Her 30+ years of experience could accelerate development of treatments for conditions with limited options.
Hidden Gut Engine Discovery Offers New Hope for Crohn’s Patients
Scientists have discovered a ‘hidden hydrogen engine’ in the gut that malfunctions in Crohn’s disease, potentially explaining digestive symptoms and opening doors to new diagnostic tools and treatments. This research offers hope for more personalized approaches to managing IBD.
Better IBD Treatments on the Horizon: What Growth Means for Patients
Market analysis shows unprecedented growth in IBD research and treatment development, with new biologics, personalized medicine, and digital health platforms on the horizon. Here’s what this expansion means for patients and families managing Crohn’s disease and ulcerative colitis.
Could This Overlooked Gut Bacteria Be a Game-Changer for IBD?
New research identifies Ruminococcus torques, a gut bacterium that strengthens the intestinal barrier and may offer new hope for IBD management. This discovery could lead to more targeted, microbiome-based therapies for inflammatory bowel disease.
